These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 6494426

  • 21. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow.
    Ichimaru M, Ishimaru T, Mikami M, Matsunaga M.
    J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540
    [Abstract] [Full Text] [Related]

  • 22. (41)Ca in Tooth Enamel. Part II: A means for retrospective biological neutron dosimetry in atomic bomb survivors.
    Rühm W, Wallner A, Cullings H, Egbert SD, El-Faramawy N, Faestermann T, Kaul D, Knie K, Korschinek G, Nakamura N, Roberts J, Rugel G.
    Radiat Res; 2010 Aug; 174(2):146-54. PubMed ID: 20681781
    [Abstract] [Full Text] [Related]

  • 23. Some effects of random dose measurement errors on analyses of atomic bomb survivor data.
    Gilbert ES.
    Radiat Res; 1984 Jun; 98(3):591-605. PubMed ID: 6729054
    [Abstract] [Full Text] [Related]

  • 24. Estimation of whole-body doses by means of chromosome aberrations observed in survivors of the Hiroshima A-bomb.
    Randolph ML, Brewen JG.
    Radiat Res; 1980 May; 82(2):393-407. PubMed ID: 7375639
    [No Abstract] [Full Text] [Related]

  • 25. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T, Hayashi Y, Takahara O, Matsuura H, Tokunaga M, Tokunaga M, Tokuoka S, Soda M, Mabuchi K, Land CE.
    Cancer; 1997 Apr 15; 79(8):1465-75. PubMed ID: 9118025
    [Abstract] [Full Text] [Related]

  • 26. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP.
    Int J Radiat Biol; 2002 Mar 15; 78(3):145-63. PubMed ID: 11869470
    [Abstract] [Full Text] [Related]

  • 27. Cataract in atomic bomb survivors based on a threshold model and the occurrence of severe epilation.
    Otake M, Neriishi K, Schull WJ.
    Radiat Res; 1996 Sep 15; 146(3):339-48. PubMed ID: 8752314
    [Abstract] [Full Text] [Related]

  • 28. Leukemia: lessons from the Japanese experience.
    Finch SC.
    Stem Cells; 1997 Sep 15; 15 Suppl 2():135-9. PubMed ID: 9368297
    [Abstract] [Full Text] [Related]

  • 29. Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors.
    Wong FL, Yamada M, Sasaki H, Kodama K, Hosoda Y.
    Radiat Res; 1999 Jun 15; 151(6):736-46. PubMed ID: 10360794
    [Abstract] [Full Text] [Related]

  • 30. The effect of changes in dosimetry on cancer mortality risk estimates in the atomic bomb survivors.
    Preston DL, Pierce DA.
    Radiat Res; 1988 Jun 15; 114(3):437-66. PubMed ID: 3375435
    [Abstract] [Full Text] [Related]

  • 31. Hyperparathyroidism among atomic bomb survivors in Hiroshima.
    Fujiwara S, Sposto R, Ezaki H, Akiba S, Neriishi K, Kodama K, Hosoda Y, Shimaoka K.
    Radiat Res; 1992 Jun 15; 130(3):372-8. PubMed ID: 1594765
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry.
    Hoshi M, Matsuura M, Hayakawa N, Ito C, Kamada N.
    Health Phys; 1996 May 15; 70(5):735-40. PubMed ID: 8690587
    [Abstract] [Full Text] [Related]

  • 34. Cancer mortality among atomic bomb survivors exposed in utero or as young children, October 1950-May 1992.
    Delongchamp RR, Mabuchi K, Yoshimoto Y, Preston DL.
    Radiat Res; 1997 Mar 15; 147(3):385-95. PubMed ID: 9052687
    [Abstract] [Full Text] [Related]

  • 35. Cytogenetic validation of DS02R1-estimated dose for atomic bomb survivors in Hiroshima and Nagasaki with FISH.
    Kodama Y, Nakamura N, Nakano M, Ohtaki K, Hamasaki K, Noda A.
    Int J Radiat Biol; 2024 Mar 15; 100(8):1155-1164. PubMed ID: 38991111
    [Abstract] [Full Text] [Related]

  • 36. Reassessment of gamma doses from the atomic bombs in Hiroshima and Nagasaki.
    Maruyama T, Kumamoto Y, Noda Y.
    Radiat Res; 1988 Jan 15; 113(1):1-14. PubMed ID: 3340713
    [Abstract] [Full Text] [Related]

  • 37. [Health effects of atomic bomb radiation].
    Shigematsu I.
    Rinsho Byori; 1994 Apr 15; 42(4):313-9. PubMed ID: 8176838
    [Abstract] [Full Text] [Related]

  • 38. Age-at-exposure effects on risk estimates for non-cancer mortality in the Japanese atomic bomb survivors.
    Zhang W, Muirhead CR, Hunter N.
    J Radiol Prot; 2005 Dec 15; 25(4):393-404. PubMed ID: 16340068
    [Abstract] [Full Text] [Related]

  • 39. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
    Sasaki MS, Endo S, Hoshi M, Nomura T.
    J Radiat Res; 2016 Nov 15; 57(6):583-595. PubMed ID: 27614201
    [Abstract] [Full Text] [Related]

  • 40. Dose-response relationship of neutron and gamma rays to chromosomally aberrant cells among atomic bomb survivors in Hiroshima and Nagasaki.
    Otake M.
    J Radiat Res; 1979 Dec 15; 20(4):307-21. PubMed ID: 536952
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.